模拟阿尔茨海默病:贝叶斯偶图形模型从人口,认知和神经成像数据
Lucas Vogels1, Reza Mohammadi1, Marit Schoonhoven1
1Amsterdam Business School, University of Amsterdam, Amsterdam, The Netherlands.
Journal of Alzheimer's disease : JAD
|May 5, 2025
概括
阿尔茨海默病的认知受到了老龄化的影响,通过大脑体积损失和粉样β积累. 女性表现出一种积极的认知相关性,但由于教育程度较低和大脑变化等因素,这种相关性会减弱.
科学领域:
- 神经科学是一个神经科学.
- 生物统计学 生物统计学
- 医疗成像医学成像
背景情况:
- 早期发现阿尔茨海默病 (AD) 需要了解复杂的特征关系.
- 条件独立性和部分相关性是确定AD中混和调解变量的关键.
- 贝叶斯高斯方圆图形模型 (GCGMs) 为分析AD相关数据提供了一种新的方法.
研究的目的:
- 用贝叶斯GCGMs估计AD中的条件依赖性和部分相关性.
- 利用GCGM处理多种数据类型 (二进制,离散,连续) 和量化不确定性的能力.
- 首次将GCGM应用于AD研究.
主要方法:
- 设计了一个GCGM来分析大脑灰质体积,葡萄糖吸收,粉样蛋白-β水平,人口统计和认知得分之间的关系.
- 将GCGM应用于跨AD阶段的健康和认知障碍参与者的队列.
- 利用贝叶斯推理来对依赖关系和相关性进行可靠的估计.
主要成果:
- 确定了三种影响认知的间接衰老途径:海马体积损失,后带皮层 (PCC) 体积损失和粉样β积累.
- 发现女性和认知之间存在积极的部分相关性,受低海马/PCC体积减弱,粉样蛋白-β增加和教育减少的影响.
- 观察到葡萄糖吸收的有限直接关系,但证实海马和PCC体积与认知有关.
结论:
- 贝叶斯式GCGM为阿尔茨海默病的病原发生提供了宝贵的见解.
- 这项研究强调了特定的神经解剖学和生物学因素,这些因素影响了阿尔茨海默病患者的认知衰退.
- 了解这些复杂的途径可以为AD的早期发现和干预策略提供信息.
相关概念视频
Alzheimer's Disease: Overview
315
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
315
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
43
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
43
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128


